Healthcare
BioGeneration and INKEF lead €4.8m round for Lanthio
BioGeneration Ventures and INKEF Capital have led a €4.8m series-A funding round for Dutch pharmaceuticals start-up Lanthio Pharma.
Blue Sea Capital acquires Dom Zdavlja Dr Ristic
Blue Sea Capital has acquired Serbian private healthcare clinic Dom Zdravlja Dr Ristic.
HTGF et al. back InnoCyte
High-Tech Gründerfonds (HTGF), the Mittelständische Beteiligungsgesellschaft (MBG) and Fraunhofer Venture have invested a six-figure sum in German medical device company InnoCyte.
21 Partners' Almaviva Sante acquires two French clinics
Almaviva Sante, portfolio company of 21 Partners, has acquired French private healthcare clinics Axium and Clinique Toutes Aures.
Capio buys healthcare division of PE-backed Ambea
Capio – a portfolio company of Apax and Nordic Capital – has acquired Carema Healthcare from Carema, the Swedish healthcare division of private equity-owned Ambea.
Wellington Partners leads series-C for Sensimed
Wellington Partners, Agate Medical Investments and Vinci Capital/Renaissance PME have invested CHF 17m in Swiss medical supplies business Sensimed.
HTGF et al. back GeneQuine Biotherapeutics
High-Tech Gründerfonds (HTGF) and Innovationsstarter Fonds Hamburg have made a seven-figure seed investment in Hamburg-based biotech company GeneQuine Biotherapeutics.
AXA PE’s Synerlab makes two acquisitions
Synerlab, a French pharmaceutical manufacturing firm backed by AXA Private Equity, has acquired Lyofal and IDD-Tech Orléans.
EdRIP to make 10x on Vessix sale
Edmond de Rothschild Investment Partners (EdRIP) stands to reap a sizeable 10x return on its original investment in US-based Vessix Vascular, following the $425m sale of the business to trade player Boston Scientific Corp.
NBGI Ventures sells TPV to Bausch + Lomb
NBGI Ventures has sold its portfolio company Technolas Perfect Vision (TPV) to Bausch + Lomb, which has exercised an option acquired in 2011.
HTGF et al. back Cysal
High-Tech Gründerfonds (HTGF) and eCapital entrepreneurial Partners AG's vehicle Gründerfonds Münsterland have invested in German biotech business Cysal.
Equistone buys Sunrise Medical Mobility from Vestar
Equistone Partners Europe has agreed to buy Sunrise Medical Mobility from Vestar Capital Partners.
ECI sells Harmoni to CareUK
ECI Partners has made a final exit from WCI Group after selling UK-based outsourced healthcare services business Harmoni to CareUK.
Waterland buys SENIOcare from Akina
Waterland has bought Swiss long-term care group SENIOcare in an SBO from Akina.
Spark backs Zilico with additional £750,000
Spark Impact has injected a further £750,000 into cancer diagnostics company Zilico Ltd.
Inveready in €3m round for Althia
Spanish VC Inveready has contributed to a €3m funding round for Althia, a biomedical firm based in Madrid.
AXA PE provides additional €100m to Ceva
AXA Private Equity has injected a further €100m into portfolio company Ceva Santé Animale, a veterinary health company.
Industrials and consumer see most volume in 2012 to date
The industrial and consumer sectors outperformed other major industries in terms of deal volume between January and September 2012.
CDC Entreprises et al. back Biom’Up with €6.8m
CDC Entreprises, Viveris Management, OTC Asset Management and exisitng investors have backed French manufacturer of medical devices Biom’Up with €6.8m.
Redx Pharma secures £4.7m for spinout
Redx Pharma has been awarded £4.7m from the British Regional Growth Fund to launch new subsidiary Redx Anti-Infectives Ltd.
TeleVenture et al. invest in APIM Therapeutics
TeleVenture, Sarsia Seed, Birk Venture and Ro Invest are said to have invested in Norwegian preclinical biotech company APIM Therapeutics.
IK Investment Partners agrees acquisition of Vemedia
IK Investment Partners and CEO Yvan Vindevogel have agreed to acquire a majority stake in Belgian pharmaceuticals supplier Vemedia Pharma.
Mid Europa buys Alpha Medical from Penta
Mid Europa Partners has wholly acquired laboratory diagnostics provider Alpha Medical from Penta Investments.
Cinven buys Amdipharm for £367m
Cinven has acquired UK-based pharmaceuticals business Amdipharm Group for £367m.